Wird geladen...
Molecular and clinical characterization of PARP9 in gliomas: A potential immunotherapeutic target
BACKGROUND: Glioma is a primary malignancy of the central nervous system (CNS). As biomedicine advances, an efficient molecular target is urgently needed for the diagnosis and treatment of glioma. Meanwhile, several studies have demonstrated that glioma development is closely related to immunity. PA...
Gespeichert in:
| Veröffentlicht in: | CNS Neurosci Ther |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7366751/ https://ncbi.nlm.nih.gov/pubmed/32678519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13380 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|